Novonesis: Harnessing nature’s potential to solve the world’s biggest challenges
BRAND STRATEGY | VISUAL IDENTITY | NAMING
Novonesis was born in 2023 from the merger of two biotech leaders, Novozymes and Chr. Hansen, with a mission to show how biosolutions — rooted in nature and powered by science — can transform industries and address humanity’s most urgent challenges.
Together with Anomaly, we defined a brand that signals Novonesis’ leadership in biotech while honouring the equity of both legacy companies. The result is a distinctive and inspiring identity — one their teams can rally behind and feel proud to represent.
-
“Transformative collaboration” became the central idea, capturing both the science and the spirit of Novonesis. As a B2B business, their biosolutions only have impact when implemented with partners — so collaboration was positioned as the heart of their story. The identity celebrates cellular networks as both scientific systems and metaphors for social change, showing how tiny agents, when united, can shift entire industries.
The visual world draws directly from microbiology, with organic forms inspired by cellular clusters in petri dishes. These shapes layer and interact to tell a story of collective progress. A Nordic-inspired, earthy colour palette grounds the brand in nature, while hand-drawn gradients convey constant change and evolution. Clean, precise typography contrasts with the organic forms, reflecting the balance between scientific rigour and natural beauty.
The identity extends across digital platforms, internal tools, and industry touchpoints, ensuring every expression of Novonesis carries its story of collaboration and impact. Internally, it became a unifying narrative, inspiring teams to embrace a shared future. Externally, it positioned Novonesis as a credible, inspiring leader redefining sustainability through biosolutions.
Agency: Anomaly Berlin | Client: Novonesis | Creative Direction: Camille Yin | Designers: Kevin Hipke, Matheus Trevisan | Strategy: Lachlan Williams
